vimarsana.com
  1. Home
  2. Live Updates
  3. Johnson Announces Final Results Of Exchange - Breaking News

Latest Breaking News On - Johnson announces final results of exchange - Page 1 : vimarsana.com

Johnson & Johnson : 2023 Third-Quarter Press Release & Supplemental Schedules -October 17, 2023 at 06:45 am EDT

Media contact: Investor contact: .

Joaquin duatoTesia williamsJessica mooreEuropean medicines agency seeking approvalExchange commissionDrug administration seekingEuropean academy of dermatologyFinalizes separation of kenvue incJohnson announces final results of exchangeJanssen highlights latest researchConsumer health companyTrueref technology for mappingNipocalimab clinical development program to address unmetConsumer healthInterventional solutionsJanssen to highlight latest research

Johnson & Johnson Reports Q3 2023 Results

2023 Third-Quarter reported sales growth of 6.8% to $21.4 Billion with operational growth of 6.4% and adjusted operational growth of 4.9% . Operational growth excluding COVID-19 Vaccine of.

Joaquin duatoJanssen to highlight latest researchFinalizes separation of kenvue incJohnson announces final results of exchangeConsumer healthEuropean commission approvesInterventional solutionsCompany consumer healthEuropean society of retina specialistsExchange commissionEuropean medicines agency seeking approval of erdafitinibEuropean academy of dermatologyJanssen highlights latest researchConsumer health companyDrug administration seeking full approvalEuropean medicines agency

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.